Shares of HIVE Blockchain Technologies Ltd. (CVE:HIV – Get Free Report) have earned a consensus rating of “Strong Buy” from the five brokerages that are covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a strong buy recommendation.
A number of research analysts have issued reports on HIV shares. Keefe, Bruyette & Woods raised shares of HIVE Blockchain Technologies to a “moderate buy” rating in a report on Wednesday, January 8th. Rosenblatt Securities raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Friday, March 7th. Finally, Roth Capital raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Wednesday, December 18th.
Check Out Our Latest Research Report on HIV
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Further Reading
- Five stocks we like better than HIVE Blockchain Technologies
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Can TikTok Stock Picks Really Make You Rich?
- Best Stocks Under $5.00
- The “Quality” Rotation: Back to Basics Investing
- 3 Warren Buffett Stocks to Buy Now
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
